{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:46:45Z","timestamp":1792007205882,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81102838"],"award-info":[{"award-number":["81102838"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Distinguished Professorship of Peking Union Medical College"},{"name":"Program for Shanghai Outstanding Academic Leader"},{"name":"New Century Excellent Talents","award":["NCET-10-0630"],"award-info":[{"award-number":["NCET-10-0630"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.ijcard.2014.05.014","type":"journal-article","created":{"date-parts":[[2014,5,17]],"date-time":"2014-05-17T15:18:35Z","timestamp":1400339915000},"page":"268-273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Plasma 15-F2t-isoprostane in idiopathic pulmonary arterial hypertension"],"prefix":"10.1016","volume":"175","author":[{"given":"Rui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Fei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin-Hua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.K.","family":"Shailendra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeenat","family":"Safdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Cheng","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.ijcard.2014.05.014_bb0005","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMra040291","article-title":"Treatment of pulmonary arterial hypertension","volume":"351","author":"Humbert","year":"2004","journal-title":"N Engl J Med"},{"issue":"8761","key":"10.1016\/j.ijcard.2014.05.014_bb0010","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0140-6736(91)90350-X","article-title":"Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis","volume":"338","author":"Borok","year":"1991","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ijcard.2014.05.014_bb0015","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/eurjhf\/hfp035","article-title":"Old and new biomarkers of heart failure","volume":"11","author":"Emdin","year":"2009","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10.1016\/j.ijcard.2014.05.014_bb0020","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1164\/rccm.200301-147OC","article-title":"Oxidative stress in severe pulmonary hypertension","volume":"169","author":"K Bowers","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.ijcard.2014.05.014_bb0025","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1164\/rccm.200702-264OC","article-title":"Gene transfer of extracellular superoxide dismutase ameliorates pulmonary hypertension in rats","volume":"177","author":"Kamezaki","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.ijcard.2014.05.014_bb0030","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1164\/ajrccm.164.6.2104033","article-title":"Increase lipid peroxidation in patients with pulmonary hypertension","volume":"164","author":"Cracowski","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"15","key":"10.1016\/j.ijcard.2014.05.014_bb0035","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1096\/fj.04-2330rev","article-title":"Isoprostanes: markers and mediators of oxidative stress","volume":"18","author":"Montuschi","year":"2004","journal-title":"FASEB J"},{"issue":"5Pt2","key":"10.1016\/j.ijcard.2014.05.014_bb0040","first-page":"R1406","article-title":"A novel mechanism for vasoconstrictor action of 8-isoprostaglandin F2 alpha on retinal vessels","volume":"274","author":"Lahaie","year":"1998","journal-title":"Am J Physiol"},{"issue":"4","key":"10.1016\/j.ijcard.2014.05.014_bb0045","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1378\/chest.11-1267","article-title":"Independent association of urinary F2-isoprostanes with survival in pulmonary arterial hypertension","volume":"142","author":"Cracowski","year":"2012","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.ijcard.2014.05.014_bb0050","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.freeradbiomed.2004.11.033","article-title":"Oxidant stress but not thromboxane decrease with epoprostenol therapy","volume":"38","author":"Robbins","year":"2005","journal-title":"Free Radic Biol Med"},{"issue":"1 Suppl.","key":"10.1016\/j.ijcard.2014.05.014_bb0055","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Updated clinical classification of pulmonary hypertension","volume":"54","author":"Simonneau","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.ijcard.2014.05.014_bb0060","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJM199505043321804","article-title":"Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage","volume":"332","author":"Morrow","year":"1995","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.ijcard.2014.05.014_bb0065","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1161\/01.CIR.98.25.2822","article-title":"Increased formation of distinct F2 isoprostanes in hypercholesterolemia","volume":"98","author":"Reilly","year":"1998","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ijcard.2014.05.014_bb0070","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/01.CIR.99.2.224","article-title":"In vivo formation of 8-iso-prostaglandin F2 alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation","volume":"99","author":"Davi","year":"1999","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.ijcard.2014.05.014_bb0075","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jacc.2009.01.004","volume":"53","author":"McLaughlin","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.ijcard.2014.05.014_bb0080","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","volume":"30","author":"Gali\u00e8","year":"2009","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ijcard.2014.05.014_bb0085","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0378-4347(00)00201-2","article-title":"Rapid and sensitive quantification of 8-isoprostaglandin F2 alpha in human plasma and urine by liquid chromatography electrospray ionization\u2013mass spectroscopy","volume":"746","author":"Ohashi","year":"2000","journal-title":"J Chromatogr B Biomed Sci Appl"},{"issue":"5","key":"10.1016\/j.ijcard.2014.05.014_bb0090","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0891-5849(00)00167-2","article-title":"Evaluation of the postprandial effects of a fast-food meal on human plasma F(2)-isoprostane levels","volume":"28","author":"Gopaul","year":"2000","journal-title":"Free Radic Biol Med"},{"issue":"5Pt1","key":"10.1016\/j.ijcard.2014.05.014_bb0095","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1164\/ajrccm.158.5.9803102","article-title":"8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases","volume":"158","author":"Montuschi","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.ijcard.2014.05.014_bb0100","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1165\/rcmb.2008-0109TR","article-title":"Isoprostanes and lung vascular pathology","volume":"39","author":"Janssen","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"16","key":"10.1016\/j.ijcard.2014.05.014_bb0105","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1161\/01.CIR.97.16.1536","article-title":"Elevated levels of 8-iso-prostaglandin F2 alpha in pericardial fluid of patients with heart failure","volume":"97","author":"Mallat","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2014.05.014_bb0110","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cca.2014.03.009","article-title":"Plasma 8-isoprostane levels are associated with endothelial dysfunction in resistant hypertension","volume":"433C","author":"de Faria","year":"2014","journal-title":"Clin Chim Acta"},{"issue":"8","key":"10.1016\/j.ijcard.2014.05.014_bb0115","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0165-6147(02)02053-9","article-title":"Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications","volume":"23","author":"Cracowski","year":"2002","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.ijcard.2014.05.014_bb0120","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1213\/01.ANE.0000153499.10558.F3","article-title":"The effect of sildenafil on pulmonary embolism-induced oxidative stress and pulmonary hypertension","volume":"101","author":"Dias-Junior","year":"2005","journal-title":"Anesth Analg"},{"issue":"3","key":"10.1016\/j.ijcard.2014.05.014_bb0125","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/cvr\/cvt109","article-title":"The phosphodiesterase-5 inhibitor vardenafil reduces oxidative stress while reversing pulmonary arterial hypertension","volume":"99","author":"Fan","year":"2013","journal-title":"Cardiovasc Res"},{"issue":"8","key":"10.1016\/j.ijcard.2014.05.014_bb0130","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1161\/01.CIR.102.8.865","article-title":"Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension","volume":"102","author":"Nagaya","year":"2000","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ijcard.2014.05.014_bb0135","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1378\/chest.129.5.1313","article-title":"Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension","volume":"129","author":"Fijalkowska","year":"2006","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ijcard.2014.05.014_bb0140","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/HJH.0b013e328332bcdb","article-title":"Nitric oxide, oxidative stress and inflammation in pulmonary arterial hypertension","volume":"28","author":"Crosswhite","year":"2010","journal-title":"J Hypertens"},{"key":"10.1016\/j.ijcard.2014.05.014_bb0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0076-6879(99)00106-8","article-title":"Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress","volume":"300","author":"Morrow","year":"1999","journal-title":"Methods Enzymol"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314009978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314009978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T03:50:48Z","timestamp":1538625048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527314009978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0167527314009978"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2014.05.014","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma 15-F2t-isoprostane in idiopathic pulmonary arterial hypertension","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2014.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}